# Hydroxychloroquine Sulfate

NDC: 0093-2401
Generic name: Hydroxychloroquine Sulfate
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20201008
Marketing ended: 20261130
FDA application: ANDA040081

## Active ingredients

- HYDROXYCHLOROQUINE SULFATE: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0093-2401"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0093-2401
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5f3e49b2-dc11-40a9-b366-c88e36a471e5